Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
ACS Chem Neurosci
2013 Mar 20;43:435-43. doi: 10.1021/cn300144v.
Show Gene links
Show Anatomy links
Quantum dot conjugates of GABA and muscimol: binding to α1β2γ2 and ρ1 GABA(A) receptors.
Gussin HA, Tomlinson ID, Cao D, Qian H, Rosenthal SJ, Pepperberg DR.
???displayArticle.abstract??? GABAA receptors are ligand-gated ion channels that mediate inhibitory synaptic signaling in the CNS. Fluorescent probes with the ability to target these receptors can provide insights into receptor location, distribution and dynamics in live cells, while revealing abnormalities in their distribution and dynamics that could occur in a variety of diseases. We have developed fluorescent probes of GABAA receptors that are composed of a CdSe/ZnS core-shell nanocrystal (quantum dot; qdot) conjugated to pegylated derivatives of the GABA receptor agonists GABA and muscimol (GABA-qdots and muscimol-qdots, respectively). Quantitative fluorescence imaging was used to analyze the binding activity of these conjugates to α1β2γ2 GABAA and ρ1 GABAA receptors expressed in Xenopus oocytes. The selectivity of these conjugates for α1β2γ2 GABAA and ρ1 GABAA receptors was determined by their ability to compete with the antagonists bicuculline and methyl-(1,2,3,6-tetrahydropyridin-4-yl)phosphinic acid (TPMPA). Both GABA- and muscimol-qdots exhibited robust binding to both α1β2γ2 and ρ1 GABAA receptors. At α1β2γ2 receptors, pretreatment with bicuculline reduced conjugate binding by ≥8-fold on average, an extent far exceeding the reduction produced by TPMPA (~30%). Conversely, at ρ1 receptors, pretreatment with TPMPA inhibited binding by ~10-fold, an extent greatly exceeding the change produced by bicuculline (~50% or less). These results indicate specific binding of muscimol-qdots and GABA-qdots to α1β2γ2 GABAA and ρ1 GABAA receptors in a manner that preserves the respective pharmacological sensitivities of these receptors to TPMPA and bicuculline, and encourage the use of qdot-conjugated neurotransmitter analogs as labeling agents at GABAA receptors.
Anikeeva,
Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response.
2006, Pubmed
Anikeeva,
Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response.
2006,
Pubmed Bentzen,
Surface modification to reduce nonspecific binding of quantum dots in live cell assays.
2005,
Pubmed Biju,
Semiconductor quantum dots and metal nanoparticles: syntheses, optical properties, and biological applications.
2008,
Pubmed Bouzigues,
Single quantum dot tracking of membrane receptors.
2007,
Pubmed Bruchez,
Semiconductor nanocrystals as fluorescent biological labels.
1998,
Pubmed Chebib,
(3-Aminocyclopentyl)methylphosphinic acids: novel GABA(C) receptor antagonists.
2007,
Pubmed
,
Xenbase Chebib,
GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology.
2000,
Pubmed Chebib,
GABAC receptor ion channels.
2004,
Pubmed Cutting,
Cloning of the gamma-aminobutyric acid (GABA) rho 1 cDNA: a GABA receptor subunit highly expressed in the retina.
1991,
Pubmed
,
Xenbase Dahan,
Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking.
2003,
Pubmed Doughty,
Benextramine-neuropeptide Y receptor interactions: contribution of the benzylic moieties to [3H]neuropeptide Y displacement activity.
1993,
Pubmed Drew,
Bicuculline- and baclofen-insensitive gamma-aminobutyric acid binding to rat cerebellar membranes.
1992,
Pubmed Enz,
Molecular composition of GABAC receptors.
1998,
Pubmed
,
Xenbase Feigenspan,
Differential pharmacology of GABAA and GABAC receptors on rat retinal bipolar cells.
1994,
Pubmed Goldman,
Multiplexed toxin analysis using four colors of quantum dot fluororeagents.
2004,
Pubmed Gussin,
Binding of muscimol-conjugated quantum dots to GABAC receptors.
2006,
Pubmed
,
Xenbase Gussin,
GABAC receptor binding of quantum-dot conjugates of variable ligand valency.
2010,
Pubmed
,
Xenbase Jaiswal,
Imaging single events at the cell membrane.
2007,
Pubmed Johnston,
GABAc receptors: relatively simple transmitter -gated ion channels?
1996,
Pubmed Kovtun,
Visualization of the cocaine-sensitive dopamine transporter with ligand-conjugated quantum dots.
2011,
Pubmed Kumar,
Novel gamma-aminobutyric acid rho1 receptor antagonists; synthesis, pharmacological activity and structure-activity relationships.
2008,
Pubmed
,
Xenbase Macdonald,
GABAA receptor channels.
1994,
Pubmed Martínez-Delgado,
An Update on GABAρ Receptors.
2010,
Pubmed Mason,
Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation.
2005,
Pubmed McBride,
Structural basis for near unity quantum yield core/shell nanostructures.
2006,
Pubmed Medintz,
Quantum dot bioconjugates for imaging, labelling and sensing.
2005,
Pubmed Olsen,
International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update.
2008,
Pubmed Olsen,
GABA A receptors: subtypes provide diversity of function and pharmacology.
2009,
Pubmed Orndorff,
Quantum dot ex vivo labeling of neuromuscular synapses.
2008,
Pubmed Pathak,
Characterization of the functional binding properties of antibody conjugated quantum dots.
2007,
Pubmed Polenzani,
Expression of mammalian gamma-aminobutyric acid receptors with distinct pharmacology in Xenopus oocytes.
1991,
Pubmed
,
Xenbase Qian,
A comparison of GABAC and rho subunit receptors from the white perch retina.
1997,
Pubmed
,
Xenbase Qian,
A single amino acid in the second transmembrane domain of GABA rho subunits is a determinant of the response kinetics of GABAC receptors.
1999,
Pubmed
,
Xenbase Qian,
Molecular and pharmacological properties of GABA-rho subunits from white perch retina.
1998,
Pubmed
,
Xenbase Ragozzino,
Design and in vitro pharmacology of a selective gamma-aminobutyric acidC receptor antagonist.
1996,
Pubmed
,
Xenbase Rajan,
Ligand-bound quantum dot probes for studying the molecular scale dynamics of receptor endocytic trafficking in live cells.
2008,
Pubmed Robinson,
Probing lectin and sperm with carbohydrate-modified quantum dots.
2005,
Pubmed Rosenthal,
Targeting cell surface receptors with ligand-conjugated nanocrystals.
2002,
Pubmed
,
Xenbase Sedelnikova,
Mapping the rho1 GABA(C) receptor agonist binding pocket. Constructing a complete model.
2005,
Pubmed Sieghart,
Subunit composition, distribution and function of GABA(A) receptor subtypes.
2002,
Pubmed Tomlinson,
Universal polyethylene glycol linkers for attaching receptor ligands to quantum dots.
2006,
Pubmed Tomlinson,
Imaging GABAc receptors with ligand-conjugated quantum dots.
2007,
Pubmed
,
Xenbase Tomlinson,
Biotin tethered homotryptamine derivatives: high affinity probes of the human serotonin transporter (hSERT).
2011,
Pubmed
,
Xenbase Tomlinson,
Peptide-conjugated quantum dots: imaging the angiotensin type 1 receptor in living cells.
2005,
Pubmed Vu,
Activation of membrane receptors by a neurotransmitter conjugate designed for surface attachment.
2005,
Pubmed
,
Xenbase Willner,
Nanoparticle-enzyme hybrid systems for nanobiotechnology.
2007,
Pubmed Xie,
2-Aminoethyl methylphosphonate, a potent and rapidly acting antagonist of GABA(A)-ρ1 receptors.
2011,
Pubmed
,
Xenbase Yamamoto,
Structurally diverse GABA antagonists interact differently with open and closed conformational states of the ρ1 receptor.
2012,
Pubmed
,
Xenbase
